Alice Blue Home
URL copied to clipboard

Trending News

Fredun Pharmaceuticals: Stock jumps after acquiring Wagr.ai

Fredun Pharmaceuticals Limited acquired Wagr.ai, including its technology platform, user base, and veterinary network, to launch India’s first neutral online marketplace for pet products and services in Q4 FY 2025-26.

Introduction

Leading pharmaceutical company acquires Wagr.ai, gaining its technology platform, 140,000+ users, and veterinary network, to launch India’s first neutral online marketplace for pet products and services in Q4 FY 2025-26.

Alice Blue Image

Also Read: Prestige Estates: Stock jumps 4% after reporting 50% YoY growth in sales in Q2

Share price movement of Fredun Pharmaceuticals

On October 10, 2025, Fredun Pharmaceuticals Ltd opened at ₹1,421.00, up 0.17% from its previous close of ₹1,418.70. The stock reached a high of ₹1,450.85 and a low of ₹1,411.00. By 1:27 PM, it traded at ₹1,424.00, a 0.37% increase, with a market cap of ₹672.36 crore.

Fredun Pharmaceuticals Acquires Wagr.ai Pet Tech Platform

Fredun Pharmaceuticals Limited acquired all assets of Wagr.ai, including its technology platform, 140,000+ user base, patented pet fitness tracking technology, and veterinary network in India.

The acquisition enables Fredun Pharmaceuticals to operate a neutral online marketplace for pet products and services in India.

Fredun Pharmaceuticals will relaunch the Wagr marketplace and services in Q4 FY 2025-26, targeting India’s pet care industry, projected to reach $6 billion by 2030.

Stock performance of Fredun Pharmaceuticals for Period of 1 week, 6 months, and 1 year

Fredun Pharmaceuticals Ltd delivered a 1.76% return over the past week. The stock gained 117% in the past six months and 74.3% over the past year.

Alice Blue Image

Also Read: Garuda Construction: Stock jumps 11% after receiving ₹144 Cr redevelopment order  at Oshiwara, Mumbai

Shareholding pattern of Fredun Pharmaceuticals

ParticularsJun 2025Mar 2025Dec 2024
Promoter48.90%48.90%48.90%
FII0%0%0%
DII1.60%1.60%1.60%
Public49.50%49.50%49.50%

About Fredun Pharmaceuticals

Fredun Pharmaceuticals Limited (BSE: 539730) is a leading innovator in India’s pet care industry, specializing in functional and prescription pet food, providing technology-driven solutions to enhance holistic pet well-being and parenting experience.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Fredun Pharmaceuticals Ltd share price going up today?

A: Fredun Pharmaceuticals Ltd share price rose after acquiring Wagr.ai, including its technology platform, 140,000+ user base, and veterinary network in India.

Q: What does Fredun Pharmaceuticals Ltd specialize in?

A: Fredun Pharmaceuticals Ltd specializes in functional and prescription pet food, providing technology-driven solutions for holistic pet care and parenting experiences.

Q: What is the 52-week high and low of Fredun Pharmaceuticals Ltd stock?

A: The 52-week high of Fredun Pharmaceuticals Ltd stock is ₹1,455.00, and the 52-week low is ₹635.00.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News

*T&C apply